Published in Medical Letter on the CDC and FDA, January 28th, 2007
An approvable letter outlines the remaining conditions that a company must meet in order to obtain FDA final marketing approval.
"We remain committed to the program and to working diligently with the FDA on any remaining issues," said Scott M. Whitcup, MD, Allergan's executive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.